Biogen expects total revenue to increase by a mid-single-digit percentage in 2026

Biogen reported third-quarter revenue of $2.80 billion and adjusted earnings per share of $2.62, beating estimates of $2.63 billion and $1.99. It expects 2026 revenue to increase by a mid-single-digit percentage and forecast full-year adjusted EPS of $12.20 to $13.00.